adopted on March 2007
|
|
- Owen Walsh
- 7 years ago
- Views:
Transcription
1 Statement of the Scientific Panel on Genetically Modified Organisms on the safe use of the nptii antibiotic resistance marker gene in genetically modified plants adopted on March BACKGROUND The Commission is currently considering the authorisation for placing on the market of the genetically modified (GM) potato line EH under Regulation (EC) No 1829/2003 on GM food and feed and under Directive 2001/18/EC, part C. The GM potato, developed for amylopectin production, also contains a nptii gene used as a selectable marker. The nptii gene codes for an aminoglycoside phosphotransferase conferring resistance to antibiotics such as kanamycin, neomycin, paromomycin, butirosin, gentamycin B and geneticin. Directive 2001/18/EC (EC, 2001) states that Member States and the Commission shall ensure that GMOs which contain genes expressing resistance to antibiotics in use for medical or veterinary treatment are taken into particular consideration when carrying out an environmental risk assessment. This is with a view to identify and phase out antibiotic resistance marker genes (ARMGs) in GMOs which may have adverse effects on human health and the environment. Over the last years, the use of antibiotic resistance marker genes for selection of GM plants, and which have been subject of safety assessment under Part C of the Directive 2001/18/EC, has been limited to the nptii gene. Some applications of GM plants submitted under Regulation No 1829/2003 also include the use of the nptii gene as a selectable marker, while in other cases the nptii gene has been excised after selection, or other markers such as the epsps and pat genes coding for herbicide tolerance were used. No other antibiotic resistance marker genes are currently present in applications submitted for approval. According to an earlier conclusion of the Scientific Panel on Genetically Modified Organisms (GMO Panel) (EFSA, 2004) 1 the use of nptii as a selectable marker in genetically modified plants and, more specifically, in the potato line EH (EFSA, 2006), does not pose a risk to the environment or to human and animal health. This conclusion was based on the low probability of gene transfer from plants to bacteria, the already widespread presence of the nptii gene in bacterial populations, and the limited use of kanamycin and neomycin in human and veterinary medicine. The Commission sought confirmation from the European Medicines Agency (EMEA) as to whether, notwithstanding a WHO working group classification of aminoglycosides as critically important antibacterials (WHO, 2005), the current or possible future uses of the antibiotics for which the nptii gene 1http:// 1
2 confers resistance is still in line with the earlier EFSA opinion. The EMEA was asked to consider whether the current or possible future medicinal uses of these antibiotics might have an impact on the earlier conclusions of the GMO Panel. In response to the Commission s request, the EMEA indicated that aminoglycosides comprise a class of antibiotics that has become increasingly important in the prevention and treatment of serious invasive bacterial infections in humans, since Gram-negative bacteria (and tuberculosis bacteria) are becoming resistant to other classes of antibiotics. The EMEA also stressed that, although kanamycin and neomycin are used relatively infrequently, the potential development of new chemical entities similar to kanamycin and neomycin should also be taken into account. In addition, although the veterinary use of kanamycin and neomycin is currently limited, aminoglycosides as a group are a class of antibiotics critically important for veterinary medicine. The EMEA considered that its competence did not extend to a detailed consideration of the likelihood of gene transfer of antibiotic resistance genes from plant material to bacteria of man and animals. Subsequently, the Commission requested EFSA (letter dated March 2, 2007) to consider the information provided by the EMEA and to indicate the potential consequences of the EMEA s conclusions on the safety assessment of the nptii gene and, where applicable, on the specific assessments of GMOs and derived food and feed. 2. ASSESSMENT A concern with respect to the presence of antibiotic resistance marker genes in GM plants is the potential for increased resistance to antibiotics in humans, animals and in organisms in the wider environment as a result of horizontal gene transfer. The safety assessment of the GMO Panel concerning the presence of the nptii gene in GM plants builds on a number of considerations. Key elements are the very low likelihood of transfer of a functional nptii gene (or any other gene), from GM plant material to microorganisms, and the prevalence of the nptii gene in bacterial clinical isolates and in the environment Likelihood of transfer of the nptii gene from the genome of GM plants to bacteria In considering the probability of functional gene transfer from plants into bacteria in the environment or human/animal gut, several aspects need to be taken into account: (i) (ii) (iii) DNA is released from plant material by normal digestion processes that take place in the gastrointestinal tract, or by activities of nucleases present in various organisms in the environment. The probability that bacteria will be exposed to DNA stretches long enough to contain the intact nptii gene is very low because of the above mentioned digestion and degradation processes (Lorenz and Wackernagel, 1994). The nptii gene from plant material can only be taken up by competent bacteria via natural transformation, a process that occurs infrequently in many bacteria and in most environmental conditions (Davison, 1999). 2
3 (iv) (v) (vi) If the intact nptii gene enters the bacteria, it will be rapidly degraded by restriction endonucleases in many bacterial cells which possess DNA restriction systems in order to destroy foreign DNA (Davison, 1999). If the intact nptii gene does indeed survive, the probability of its incorporation into the bacterial genome is very low unless there are homologous regions already present in the bacterial genome. Gene transfer from plants to bacteria has only been demonstrated under laboratory conditions when regions of homology were already present in the recipient bacterium (Bennett et al., 2004, de Vries et al., 2001, de Vries and Wackernagel, 2002, Kay et al., 2002, Tepfer et al., 2003). Expression of the incorporated nptii gene is unlikely considering that in GM plant material the nptii gene is under the control of a promoter with preferential expression in plants, which does not support its efficient expression in bacteria. (vii) Stable integration and inheritance of the nptii gene in the host bacterium is not likely in the absence of selective pressure from a relevant antibiotic. When all of the above mentioned aspects are taken into account, the probability of functional gene transfer from plants into microorganisms is extremely low. It is not surprising that transfer of an antibiotic resistance marker from GM plants to bacteria has not been observed under natural conditions (Gay and Gillespie, 2005). The EMEA has indicated that under laboratory conditions gene transfer from plants to bacteria has been demonstrated. EFSA has addressed this issue more extensively in its Opinion of 2004 (section 4) (EFSA, 2004). Gene transfer from plants to bacteria has only been demonstrated in a few highly transformable bacterial species (e.g., Acinetobacter sp. BD413 or Pseudomonas stutzeri) under artificial and forced laboratory conditions when regions of homology were already present in the recipient bacterium (Bennett et al., 2004, de Vries et al., 2001, de Vries and Wackernagel, 2002, Kay et al., 2002, Tepfer et al., 2003). In the absence of this optimisation of the process and selection pressure, resistance gene transfer from GM plants to bacteria, even in the laboratory, could not be demonstrated (Gebhard and Smalla, 1998) Prevalence of the nptii gene in soil, humans and animals As indicated in the Opinion (of the GMO Panel) on the use of antibiotic resistance genes as markers in GM plants, antibiotic resistance is a common feature in natural microbial communities in soils, aquatic systems, and habitats associated with animals and humans (EFSA, 2004). There is already a widespread presence of nptii in the soil environment as evidenced from DNA-based work with nptii as a probe in different locations in Western Europe (NSCFFS, 2005, Smalla et al., 1993) and in the USA (Leff et al., 1993). Studies indicate that, as expected of a gene located on a transposable genetic element, nptii is located on a wide range of replicons in bacterial clinical isolates from humans (Alvarez and Mendoza, 1992, Chang et al., 1992, Flamm et al., 1993). The nptii gene was present in 2.5% of bacterial clinical isolates resistant to kanamycin and neomycin collected between 1987 and 1991 in several European and Central and South American countries (Shaw et al., 1993). Studies on the prevalence of the nptii gene in animal-associated bacterial populations have not been found in the scientific literature. 3
4 2.3. Contribution of the nptii gene to the prevalence of resistance to kanamycin Kanamycin-resistant bacteria are ubiquitous in nature. Selective plating of different environmental samples on kanamycin-containing medium reduced the microbial count from 10 7 to 10 4 CFU/g (Smalla and van Elsas, 1996, Smalla et al., 1993). Only a fraction of kanamycin-resistant bacteria contain the nptii (aph(3 )- IIa) gene, the other resistant bacteria having different genes and/or other mechanisms conferring kanamycin resistance. The nptii gene has been reported to occur naturally only in eubacteria. In one survey, 3 out of 184 kanamycin resistant bacterial isolates from three stream sites in the USA (Leff et al., 1993) and 44 out of 355 from different habitats in the Netherlands (Smalla et al., 1993) contained nptii sequences Potential mutations of the nptii gene resulting in resistance to other antibiotics As reported in the opinion of the GMO Panel on antibiotic resistance genes as markers in GM plants (EFSA, 2004), resistance towards amikacin, an important reserve antibiotic could be obtained under laboratory conditions and was the result of a mutated nptii gene and a diminished rate of amikacin uptake into the bacterial cell (Perlin and Lerner, 1986). The increased affinity of a mutated nptii gene product for amikacin was later confirmed by site-directed mutagenesis which resulted in one altered nucleotide in the gene and an eight-fold increase in amikacin resistance in E.coli (Kocabiyik and Perlin, 1992). It has been suggested that the increased affinity for amikacin conferred by this mutation, might impair the clinical effectiveness of the drug. However, to date no clinical amikacin resistant strains with a mutated nptii gene have been identified. 3. CONCLUSIONS The GMO Panel agrees with the EMEA that the preservation of the therapeutic potential of the aminoglycoside group of antibiotics is important. The Panel is also of the opinion that the therapeutic effect of these antibiotics will not be compromised by the presence of the nptii gene in GM plants, given the extremely low probability of gene transfer from plants to bacteria and its subsequent expression. Furthermore, the GMO Panel considers it very unlikely that the presence of the nptii gene in GM plants will change the existing widespread prevalence of this antibiotic resistance gene in bacterial sources in the environment. The GMO Panel also points to evidence which indicates that integration of the nptii gene would only be one of many mechanisms by which bacteria could become resistant to aminoglycosides such as kanamycin. Therefore, the GMO Panel reiterates its earlier conclusions (EFSA, 2004) that the use of the nptii gene as selectable marker in GM plants (and derived food or feed) does not pose a risk to human or animal health or to the environment. The GMO Panel also confirms earlier safety assessments of GM plants and derived food/feed comprising the nptii gene. The GMO Panel emphasizes that the use of antibiotic resistance marker genes in GM plants has been the subject of several reviews (Gay and Gillespie, 2005, Goldstein et al., 2005, Miki and McHugh, 2004, Nap et al., 1992, Nielsen et al., 1998, Ramessar et al., 2007) and expert consultations: Working Party of the British Society for Antimicrobial Chemotherapy (Bennett et al., 2004), FAO/WHO Consultation on Foods Derived from Biotechnology (FAO/WHO, 2000), Scientific Steering Committee of the European Commission (SSC, 1999) Zentrale Kommission für die Biologische Sicherheit, DE (ZKBS, 1999), The Advisory Committee on 4
5 Novel Foods and Processes, UK (ACNFP, 1996). It has been concluded in these reports that the frequencies of gene transfer from plants to bacteria are likely to be extremely low and that the presence of antibiotic resistance marker genes, and in particular the nptii gene, in GM plants do not pose a relevant risk to human or animal health or to the environment. DOCUMENTATION PROVIDED TO EFSA 1. Letter from DG SANCO, dated 2 March 2007, concerning the presence of the nptii resistance gene in genetically modified organisms (ref. SANCO/E1/SG/cc (2007)D/510137). 2. Document from the EMEA Committee for Medicinal Products for Veterinary Use and Committee for Medicinal Products for Human Use, dated 22 February 2007, entitled Presence of the antibiotic resistance marker gene nptii in GM plants for food and feed uses, (ref. EMEA/CVMP/56937/2007-Final). REFERENCES ACNFP (1996) The use of antibiotic resistance markers in genetically modified plants for human food. The Advisory Committee on Novel Foods and Processes, UK. ALVAREZ, M. & MENDOZA, M. C. (1992) Epidemiological survey of genes encoding aminoglycoside phosphotransferases APH (3') I and APH (3') II using DNA probes. J. Chemother., 4, BENNETT, P. M., LIVESEY, C. T., NATHWANI, D., REEVES, D. S., SAUNDERS, J. R. & WISE, R. (2004) An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother., 53, CHANG, S. F., CHANG, L. L., CHOW, T. Y., WU, W. J. & CHANG, J. C. (1992) Prevalence of transposons encoding kanamycin, ampicillin and trimethoprim resistance in isolates from urinary tract infections detected using DNA probes. Gaoxiong Yi Xue Ke Xue Za Zhi, 8, DAVISON, J. (1999) Genetic exchange between bacteria in the environment. Plasmid, 42, DE VRIES, J., MEIER, P. & WACKERNAGEL, W. (2001) The natural transformation of the soil bacteria Pseudomonas stutzeri and Acinetobacter sp. by transgenic plant DNA strictly depends on homologous sequences in the recipient cells. FEMS Microbiol. Lett., 195, DE VRIES, J. & WACKERNAGEL, W. (2002) Integration of foreign DNA during natural transformation of Acinetobacter sp. by homology-facilitated illegitimate recombination. Proc. Natl. Acad. Sci. USA, 99, EFSA (2004) Opinion of the Scientific Panel on Genetically Modified Organisms on the use of antibiotic resistance genes as marker genes in genetically modified plants (Question N EFSA-Q ). The EFSA Journal, 48,
6 EFSA (2006) Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-UK ) for the placing on the market of genetically modified potato EH with altered starch composition, for production of starch and food/feed uses, under Regulation (EC) No 1829/2003 from BASF Plant Science. The EFSA Journal, 324, FAO/WHO (2000) Safety aspects of genetically modified foods of plant origin. Report of a Joint FAO/WHO Expert Consultation on Foods Derived from Biotechnology., World Health Organization. FLAMM, R. K., PHILLIPS, K. L., TENOVER, F. C. & PLORDE, J. J. (1993) A survey of clinical isolates of Enterobacteriaceae using a series of DNA probes for aminoglycoside resistance genes. Mol. Cell. Probes, 7, GAY, P. B. & GILLESPIE, S. H. (2005) Antibiotic resistance markers in genetically modified plants: a risk to human health? Lancet Infect. Dis., 5, GEBHARD, F. & SMALLA, K. (1998) Transformation of Acinetobacter sp. strain BD413 by transgenic sugar beet DNA. Appl. Environ. Microbiol., 64, GOLDSTEIN, D. A., TINLAND, B., GILBERTSON, L. A., STAUB, J. M., BANNON, G. A., GOODMAN, R. E., MCCOY, R. L. & SILVANOVICH, A. (2005) Human safety and genetically modified plants: a review of antibiotic resistance markers and future transformation selection technologies. J. Appl. Microbiol., 99, KAY, E., VOGEL, T. M., BERTOLLA, F., NALIN, R. & SIMONET, P. (2002) In situ transfer of antibiotic resistance genes from transgenic (transplastomic) tobacco plants to bacteria. Appl. Environ. Microbiol., 68, KOCABIYIK, S. & PERLIN, M. H. (1992) Altered substrate specificity by substitutions at Tyr218 in bacterial aminoglycoside 3'-phosphotransferase-II. FEMS Microbiol. Lett., 72, LEFF, L. G., DANA, J. R., MCARTHUR, J. V. & SHIMKETS, L. J. (1993) Detection of Tn5-like sequences in kanamycin-resistant stream bacteria and environmental DNA. Appl. Environ. Microbiol., 59, LORENZ, M. G. & WACKERNAGEL, W. (1994) Bacterial gene transfer by natural genetic transformation in the environment. Microbiol. Rev., 58, MIKI, B. & MCHUGH, S. (2004) Selectable marker genes in transgenic plants: applications, alternatives and biosafety. J. Biotechnol., 107, NAP, J. P., BIJVOET, J. & STIEKEMA, W. J. (1992) Biosafety of kanamycin-resistant transgenic plants. Transgenic Res., 1, NIELSEN, K. M., BONES, A. M., SMALLA, K. & VAN ELSAS, J. D. (1998) Horizontal gene transfer from transgenic plants to terrestrial bacteria--a rare event? FEMS Microbiol. Rev., 22, NSCFFS (2005) An assessment on potential long-term health effects caused by antibiotic resistance marker genes in genetically modified organisms based on antibiotic usage and resistance patterns in Norway. Report from an Ad Hoc Group appointed by the Norwegian Scientific Panel on Genetically Modified Organisms and Panel on Biological Hazards. Norwegian Scientific Committee for Food Safety. 6
7 PERLIN, M. H. & LERNER, S. A. (1986) High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake. Antimicrob. Agents Chemother., 29, RAMESSAR, K., PEREMARTI, A., GOMEZ GALERA, S., NAQVI, S., MORALEJO, M., MUÑOZ, P., CAPELL, T. & CHRISTOU, P. (2007) Biosafety and risk assessment framework for selectable marker genes in transgenic crop plants. A case of the science not supporting the politics. Transgenic Res. (in press). SHAW, K. J., RATHER, P. N., HARE, R. S. & MILLER, G. H. (1993) Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev., 57, SMALLA, K. & VAN ELSAS, J. D. (1996) Monitoring genetically modified organisms and their recombinant DNA in soil environments. IN TOMIUK, J., WÖHRMANN, K. & SENTKER, A. (Eds.) Transgenic organisms - biological and social implications. Basel, Switzerland, Birkhäuser Verlag. SMALLA, K., VAN OVERBEEK, L. S., PUKALL, R. & VAN ELSAS, J. D. (1993) Prevalence of nptii and Tn5 in kanamycin-resistant bacteria from different environments. FEMS Microbiol. Ecol., 13, SSC (1999) Opinion of the Scientific Steering Committee on Antimicrobial Resistance. European Commission. Directorate-General XXIV. TEPFER, D., GARCIA-GONZALES, R., MANSOURI, H., SERUGA, M., MESSAGE, B., LEACH, F. & PERICA, M. C. (2003) Homology-dependent DNA transfer from plants to a soil bacterium under laboratory conditions: implications in evolution and horizontal gene transfer. Transgenic Res., 12, WHO (2005) Critically Important Antibacterial Agents for Human Medicine for Risk Management Strategies of Non-Human Use. Report of a WHO working group consultation, February 2005, Canberra, Australia., World Health Organization. ZKBS (1999) Stellungnahme der ZKBS zur Biologischen Sicherheit von Antibiotika-Resistenzgenen im Genom gentechnisch veränderter Pflanzen. Zentrale Kommission für die Biologische Sicherheit, DE, Gentechnik/093 ZKBS/01 Allg Stellun gnahmen/01 generellethemen/generellethemen node.html nnn=true. SCIENTIFIC PANEL MEMBERS Hans Christer Andersson, Salvatore Arpaia, Detlef Bartsch, Josep Casacuberta, Howard Davies, Lieve Herman, Marc De Loose, Niels Hendriksen, Sirpa Kärenlampi, Jozsef Kiss, Ilona Kryspin-Sørensen, Harry Kuiper, Ingolf Nes, Nickolas Panopoulos, Joe Perry, Annette Pöting, Joachim Schiemann, Willem Seinen, Jeremy Sweet, and Jean-Michel Wal. ACKNOWLEDGEMENT The GMO Panel wishes to thank Hans Jörg Buhk, Patrick Du Jardin, Boet Glandorf, John Heritage, Fergal O Gara, Armine Sefton, Philippe Vain, and Jan Dick van Elsas for their contributions to the statement. 7
COMMISSION OF THE EUROPEAN COMMUNITIES. Draft COMMISSION DECISION
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Draft Brussels, COMMISSION DECISION of authorising the placing on the market of food and feed containing, consisting of, or produced from the genetically
More informationEVENT REPORT. European Food Safety Authority 3. European Food Safety Authority (EFSA), Parma, Italy
Supporting Publications 2012:EN-317 EVENT REPORT Bilateral technical meeting between members of the EFSA Panels on Genetically Modified Organisms and Biological Hazards and the Austrian delegation on the
More informationTHROWING CAUTION TO THE WIND. A review of the European Food Safety Authority and its work on genetically modified foods and crops.
THROWING CAUTION TO THE WIND A review of the European Food Safety Authority and its work on genetically modified foods and crops. November 2004 TABLE OF CONTENTS SUMMARY... 3 1. INTRODUCTION... 5 2. WHAT
More informationFACULTY OF MEDICAL SCIENCE
Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research
More informationGENE CLONING AND RECOMBINANT DNA TECHNOLOGY
GENE CLONING AND RECOMBINANT DNA TECHNOLOGY What is recombinant DNA? DNA from 2 different sources (often from 2 different species) are combined together in vitro. Recombinant DNA forms the basis of cloning.
More informationRecombinant DNA and Biotechnology
Recombinant DNA and Biotechnology Chapter 18 Lecture Objectives What Is Recombinant DNA? How Are New Genes Inserted into Cells? What Sources of DNA Are Used in Cloning? What Other Tools Are Used to Study
More informationHow To Know If A Genetically Modified Potato Is Safe
Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the notification (Reference C/SE/96/3501) for the placing on the market of genetically modified
More informationParma, 22 August 2012 EFSA / Unit /GMO. Agreed by the WG on 22 August 2012
Parma, 22 August 2012 SCIENTIFIC PANEL ON GENETICALLY MODIFIED ORGANISMS Minutes of the 32 nd meeting of the Working Group on Genetically Modified Parma, 22 August 2012 EFSA / Unit /GMO Agreed by the WG
More informationCHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA
CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA INTRODUCTION DNA : DNA is deoxyribose nucleic acid. It is made up of a base consisting of sugar, phosphate and one nitrogen base.the
More informationwww.biochemj.org/bj/330/0581/bj3300581.htm
Ribosomes as Antibiotic Targets www.biochemj.org/bj/330/0581/bj3300581.htm Ware, Bioscience in the 21 st Century, 2009 PERSPECTIVE Widespread use of antibiotics after WWII improved human health globally
More informationGenetic Engineering and Biotechnology
1 So, what is biotechnology?? The use of living organisms to carry out defined chemical processes for industrial or commercial application. The office of Technology Assessment of the U.S. Congress defines
More informationAP BIOLOGY 2007 SCORING GUIDELINES
AP BIOLOGY 2007 SCORING GUIDELINES Question 4 A bacterial plasmid is 100 kb in length. The plasmid DNA was digested to completion with two restriction enzymes in three separate treatments: EcoRI, HaeIII,
More informationEuropean Medicines Agency
European Medicines Agency July 1996 CPMP/ICH/139/95 ICH Topic Q 5 B Quality of Biotechnological Products: Analysis of the Expression Construct in Cell Lines Used for Production of r-dna Derived Protein
More informationMilestones of bacterial genetic research:
Milestones of bacterial genetic research: 1944 Avery's pneumococcal transformation experiment shows that DNA is the hereditary material 1946 Lederberg & Tatum describes bacterial conjugation using biochemical
More informationMDM. Metabolic Drift Mutations - Attenuation Technology
MDM Metabolic Drift Mutations - Attenuation Technology Seite 2 Origin of MDM attenuation technology Prof. Dr. Klaus Linde Pioneer in R&D of human and animal vaccines University of Leipzig Germany Origin
More informationAntimicrobial Resistance and Human Health
Antimicrobial Resistance and Human Health Dearbháile Morris, Discipline of Bacteriology, School of Medicine, National University of Ireland, Galway The microbial world The is a gene Talk cloud in a The
More informationCOMMISSION IMPLEMENTING REGULATION (EU) No /.. of XXX
Ref. Ares(2013)222755-20/02/2013 EUROPEAN COMMISSION Brussels, XXX SANCO/12462/2011 Rev. 2 (POOL/E1/2011/12462/12462R2- EN.doc) [ ](2012) XXX draft COMMISSION IMPLEMENTING REGULATION (EU) No /.. of XXX
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS
More informationhttp://www.springer.com/3-540-20178-5
http://www.springer.com/3-540-20178-5 92 3 Regulation, Assessment and Monitoring of GMOs 3.4.4 Field releases and Commercialisation of GMOs in CEE Countries Until 2003, only experimental field trial releases
More informationSite-Directed Nucleases and Cisgenesis Maria Fedorova, Ph.D.
Site-Directed Nucleases and Cisgenesis Maria Fedorova, Ph.D. Regulatory Strategy Lead Enabling Technologies DuPont-Pioneer, USA 1 New Plant Breeding Techniques 2007 New Techniques Working Group established
More informationThe E. coli Insulin Factory
The E. coli Insulin Factory BACKGROUND Bacteria have not only their normal DNA, they also have pieces of circular DNA called plasmids. Plasmids are a wonderfully ally for biologists who desire to get bacteria
More informationOverview on EFSA data requirements for the safety evaluation of food enzymes applications
Overview on EFSA data requirements for the safety evaluation of food enzymes applications Fidel Toldrá and Klaus-Dieter Jany EFSA CEF Panel Info session on Food Enzymes applications Parma, 27 May 2014
More informationrestriction enzymes 350 Home R. Ward: Spring 2001
restriction enzymes 350 Home Restriction Enzymes (endonucleases): molecular scissors that cut DNA Properties of widely used Type II restriction enzymes: recognize a single sequence of bases in dsdna, usually
More informationChapter 23 Definitions of GMO/LMO and modern biotechnology. Three different definitions but the same legal interpretation?
Chapter 23 Definitions of GMO/LMO and modern biotechnology JAN HUSBY NORWEGIAN INSTITUTE OF GENE ECOLOGY (GENØK), TROMSØ, NORWAY Three different definitions but the same legal interpretation? There are
More informationIntroductory Biotechnology for High School Teachers - UNC-Wilmington
Workshop Dates: June 20-24, 2011 Introductory Biotechnology for High School Teachers - UNC-Wilmington Participants will learn basic scientific concepts and techniques in biotechnology, as well as how to
More informationTransfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.
Transfection Key words: Transient transfection, Stable transfection, transfection methods, vector, plasmid, origin of replication, reporter gene/ protein, cloning site, promoter and enhancer, signal peptide,
More informationEU Reference Laboratory for E. coli Department of Veterinary Public Health and Food Safety Unit of Foodborne Zoonoses Istituto Superiore di Sanità
EU Reference Laboratory for E. coli Department of Veterinary Public Health and Food Safety Unit of Foodborne Zoonoses Istituto Superiore di Sanità Inventory of the expertise on molecular typing of Verocytotoxin-producing
More informationGenetic Technology. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.
Name: Class: Date: Genetic Technology Multiple Choice Identify the choice that best completes the statement or answers the question. 1. An application of using DNA technology to help environmental scientists
More information2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey
2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey Antibiotic resistance is a global issue that has significant impact in the field of infectious diseases.
More informationInnovations in Molecular Epidemiology
Innovations in Molecular Epidemiology Molecular Epidemiology Measure current rates of active transmission Determine whether recurrent tuberculosis is attributable to exogenous reinfection Determine whether
More informationA and B are not absolutely linked. They could be far enough apart on the chromosome that they assort independently.
Name Section 7.014 Problem Set 5 Please print out this problem set and record your answers on the printed copy. Answers to this problem set are to be turned in to the box outside 68-120 by 5:00pm on Friday
More informationCCR Biology - Chapter 9 Practice Test - Summer 2012
Name: Class: Date: CCR Biology - Chapter 9 Practice Test - Summer 2012 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Genetic engineering is possible
More informationStatement of ethical principles for biotechnology in Victoria
Statement of ethical principles for biotechnology in Victoria Statement of ethical principles for biotechnology in Victoria Acknowledgments Published by the Public Health Group, Rural & Regional Health
More informationAnnex 6: Nucleotide Sequence Information System BEETLE. Biological and Ecological Evaluation towards Long-Term Effects
Annex 6: Nucleotide Sequence Information System BEETLE Biological and Ecological Evaluation towards Long-Term Effects Long-term effects of genetically modified (GM) crops on health, biodiversity and the
More informationRestriction Endonucleases
Nucleic Acids and Molecular Biology 14 Restriction Endonucleases Bearbeitet von Alfred Pingoud 1. Auflage 2004. Buch. xxvi, 443 S. Hardcover ISBN 978 3 540 20502 9 Format (B x L): 15,5 x 23,5 cm Gewicht:
More informationLecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology
Lecture 13: DNA Technology DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology DNA Sequencing determine order of nucleotides in a strand of DNA > bases = A,
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT OF POST-MARKETING SURVEILLANCE STUDIES OF VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/CVMP/044/99-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT
More informationNOVA SOUTHEASTERN UNIVERSITY. Bacterial Evolutionary Genetics Course Graduate Level Oceanographic Center NOVA Southeastern University
NOVA SOUTHEAST UNIVERSITY Bacterial Evolutionary Genetics Course Graduate Level Oceanographic Center NOVA Southeastern University Lecture Time: Location: Instructor: Telephone: ON-LINE SUMMER SESSION May
More informationChapter 6 DNA Replication
Chapter 6 DNA Replication Each strand of the DNA double helix contains a sequence of nucleotides that is exactly complementary to the nucleotide sequence of its partner strand. Each strand can therefore
More informationTestbiotech analysis of EFSA Guidance on the environmental risk assessment of genetically modified plants. Table of Contents
TESTBIOTECH Background 21-12-2010 Testbiotech analysis of EFSA Guidance on the environmental risk assessment of genetically modified plants EFSA s standards for environmental risk assessment not sufficient
More informationFAQs: Gene drives - - What is a gene drive?
FAQs: Gene drives - - What is a gene drive? During normal sexual reproduction, each of the two versions of a given gene has a 50 percent chance of being inherited by a particular offspring (Fig 1A). Gene
More informationMASTER OF SCIENCE IN BIOLOGY
MASTER OF SCIENCE IN BIOLOGY The Master of Science in Biology program is designed to provide a strong foundation in concepts and principles of the life sciences, to develop appropriate skills and to inculcate
More informationHCS604.03 Exercise 1 Dr. Jones Spring 2005. Recombinant DNA (Molecular Cloning) exercise:
HCS604.03 Exercise 1 Dr. Jones Spring 2005 Recombinant DNA (Molecular Cloning) exercise: The purpose of this exercise is to learn techniques used to create recombinant DNA or clone genes. You will clone
More informationMicromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting -
A Microbiology Services Company Lab Services Research - Consulting - Regulatory Company description is a microbiology services company specializing in antiinfective discovery and development for the pharmaceutical,
More informationGreen Fluorescent Protein (GFP): Genetic Transformation, Synthesis and Purification of the Recombinant Protein
Green Fluorescent Protein (GFP): Genetic Transformation, Synthesis and Purification of the Recombinant Protein INTRODUCTION Green Fluorescent Protein (GFP) is a novel protein produced by the bioluminescent
More informationArabidopsis. A Practical Approach. Edited by ZOE A. WILSON Plant Science Division, School of Biological Sciences, University of Nottingham
Arabidopsis A Practical Approach Edited by ZOE A. WILSON Plant Science Division, School of Biological Sciences, University of Nottingham OXPORD UNIVERSITY PRESS List of Contributors Abbreviations xv xvu
More informationLecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)
Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Single nucleotide polymorphisms or SNPs (pronounced "snips") are DNA sequence variations that occur
More informationBiotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College
Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Primary Source for figures and content: Eastern Campus Tortora, G.J. Microbiology
More informationGUIDELINES FOR RISK ANALYSIS OF FOODBORNE ANTIMICROBIAL RESISTANCE CAC/GL 77-2011
CAC/GL 77-2011 Page 1 of 29 GUIDELINES FOR RISK ANALYSIS OF FOODBORNE ANTIMICROBIAL RESISTANCE CAC/GL 77-2011 Table of Contents Introduction Scope Definitions General Principles for Foodborne AMR Risk
More informationConstruction of Biologically Functional Bacterial Plasmids In Vitro
Proc. Nat. Acad. Sci. USA Vol. 70, No. 11, pp. 3240-3244, November 1973 Construction of Biologically Functional Bacterial Plasmids In Vitro (R factor/restriction enzyme/transformation/endonuclease/antibiotic
More information4. DNA replication Pages: 979-984 Difficulty: 2 Ans: C Which one of the following statements about enzymes that interact with DNA is true?
Chapter 25 DNA Metabolism Multiple Choice Questions 1. DNA replication Page: 977 Difficulty: 2 Ans: C The Meselson-Stahl experiment established that: A) DNA polymerase has a crucial role in DNA synthesis.
More informationFrequently Asked Questions about FAO and Agricultural Biotechnology. 5. What is FAO s position on release of GMOs in any specific country?
Frequently Asked Questions about FAO and Agricultural Biotechnology 1. What is agricultural biotechnology? 2. What are GMOs? 3. Are GMOs widely used in food and agriculture today? 4. What is FAO s position
More informationPrinciples of Evolution - Origin of Species
Theories of Organic Evolution X Multiple Centers of Creation (de Buffon) developed the concept of "centers of creation throughout the world organisms had arisen, which other species had evolved from X
More informationBachelor of Science in Applied Bioengineering
Bachelor of Science in Applied Bioengineering Applied bioengineering employs scientific and engineering principles to process biological materials from biological agents for provision of goods and related
More informationGenetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association
6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising
More informationBiotechnology: DNA Technology & Genomics
Chapter 20. Biotechnology: DNA Technology & Genomics 2003-2004 The BIG Questions How can we use our knowledge of DNA to: diagnose disease or defect? cure disease or defect? change/improve organisms? What
More informationTuesday 14 May 2013 Morning
THIS IS A NEW SPECIFICATION H Tuesday 14 May 2013 Morning GCSE TWENTY FIRST CENTURY SCIENCE BIOLOGY A A161/02 Modules B1 B2 B3 (Higher Tier) *A137150613* Candidates answer on the Question Paper. A calculator
More informationNo. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9637/08 SAN 88 DENLEG 52 VETER 7 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER
More informationWater and Wastewater. Sample Collection and Analysis
Water and Wastewater Sample Collection and Analysis December 2011 Introduction Accurate testing of drinking water is crucial to maintaining the health and safety of Islanders who rely on this resource.
More informationA Correlation of Miller & Levine Biology 2014
A Correlation of Miller & Levine Biology To Ohio s New Learning Standards for Science, 2011 Biology, High School Science Inquiry and Application Course Content A Correlation of, to Introduction This document
More informationTwincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie
Twincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie 0 HELMHOLTZ I ZENTRUM FÜR INFEKTIONSFORSCHUNG Technische Universität Braunschweig Institut
More informationGenetics Test Biology I
Genetics Test Biology I Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Avery s experiments showed that bacteria are transformed by a. RNA. c. proteins.
More informationBIOTECHNOLOGY OPERATIONS
BIOTECHNOLOGY OPERATIONS Principles and Practices Michael J. Roy TECHNISCHE INFORMATION SBIBLIOTHEK UNIVERSITATSBIBLIOTHEK HANNOVER CRC Press TaylorStFrancis Croup Boca Raton London New York CRC Press
More informationBasic Concepts Recombinant DNA Use with Chapter 13, Section 13.2
Name Date lass Master 19 Basic oncepts Recombinant DN Use with hapter, Section.2 Formation of Recombinant DN ut leavage Splicing opyright lencoe/mcraw-hill, a division of he Mcraw-Hill ompanies, Inc. Bacterial
More informationEuropean Food Safety Authority: A playing field for the biotech industry. Table of Contents. TESTBIOTECH Background 1-12-2010
TESTBIOTECH Background 1-12-2010 European Food Safety Authority: A playing field for the biotech industry Standards for risk assessment massively influenced by industry Christoph Then and Andreas Bauer-Panskus
More informationTransformation of the bacterium E. coli. using a gene for Green Fluorescent Protein
Transformation of the bacterium E. coli using a gene for Green Fluorescent Protein Background In molecular biology, transformation refers to a form of genetic exchange in which the genetic material carried
More informationManagement of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings
Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings Dr. Mary Vearncombe PIDAC-IPC February 2012 Objectives: To provide an overview of the RP/AP Annex
More informationHeading/title. Health and Safety Executive
Heading/title Health and Safety Executive The SACGM Compendium of guidance Part 4: Genetic modification work that involves plants (including plant-associated genetically modified microorganisms) HSE Books
More informationLocalised Sex, Contingency and Mutator Genes. Bacterial Genetics as a Metaphor for Computing Systems
Localised Sex, Contingency and Mutator Genes Bacterial Genetics as a Metaphor for Computing Systems Outline Living Systems as metaphors Evolutionary mechanisms Mutation Sex and Localized sex Contingent
More informationGUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS
GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS -ii- GUIDELINES ON THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND
More informationExpression of Bt toxins in 'SmartStax'
TESTBIOTECH Background 28-6 - 2011 Expression of Bt toxins in 'SmartStax' Analyses of Stilwell & Silvanovich, 2007 and Phillips, 2008 Report number MSL0021070 and Sub-Report ID: 61026.05 Christoph Then
More informationGene mutation and molecular medicine Chapter 15
Gene mutation and molecular medicine Chapter 15 Lecture Objectives What Are Mutations? How Are DNA Molecules and Mutations Analyzed? How Do Defective Proteins Lead to Diseases? What DNA Changes Lead to
More informationTransmission of genetic variation: conjugation. Transmission of genetic variation: conjugation
Transmission of genetic variation: conjugation Transmission of genetic variation: conjugation Bacterial Conjugation is genetic recombination in which there is a transfer of DNA from a living donor bacterium
More informationpmod2-puro A plasmid containing a synthetic Puromycin resistance gene Catalog # pmod2-puro For research use only Version # 11H29-MM
pmod2-puro A plasmid containing a synthetic Puromycin resistance gene Catalog # pmod2-puro For research use only Version # 11H29-MM PrOduct information content: - 20 mg of lyophilized pmod2-puro plasmid
More information7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology)
7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology) Students should fulfill a total of 38 credit hours: 1- Basic requirements: 10 credit hours. 150701, 150702, 150703,
More informationDOE Office of Biological & Environmental Research: Biofuels Strategic Plan
DOE Office of Biological & Environmental Research: Biofuels Strategic Plan I. Current Situation The vast majority of liquid transportation fuel used in the United States is derived from fossil fuels. In
More informationBiological Sciences Initiative. Human Genome
Biological Sciences Initiative HHMI Human Genome Introduction In 2000, researchers from around the world published a draft sequence of the entire genome. 20 labs from 6 countries worked on the sequence.
More informationExpression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu
Expression and Purification of Recombinant Protein in bacteria and Yeast Presented By: Puspa pandey, Mohit sachdeva & Ming yu DNA Vectors Molecular carriers which carry fragments of DNA into host cell.
More informationPART A2: DATA OR RESULTS FROM ANY PREVIOUS RELEASES OF THE GMO
APPLICATION FOR CONSENT TO RELEASE A GMO PART A2: DATA OR RESULTS FROM ANY PREVIOUS RELEASES OF THE GMO Give information on data or results from any previous releases of this GMO by you either inside or
More informationAnswer Key. Vocabulary Practice
Answer Key Vocabulary Practice Copyright by McDougal Littell, a division of Houghton Mifflin Company A. Categorize Words 1. organism, L; cell, L; species, L; transgenic, B; biotechnology, T; molecular
More informationGenetic Variation and Molecular Evolution
1 Genetic Variation and Molecular Evolution Werner Arber Biozentrum, University of Basel, Klingelbergstrasse 70, Basel, Switzerland 1 Introduction 3 2 Principles of Molecular Evolution 4 2.1 Evolutionary
More informationPublic Perceptions of Labeling Genetically Modified Foods
Public Perceptions of Labeling Genetically Modified Foods Working Paper 2013-01 William K. Hallman, Ph.D. Cara L. Cuite, Ph.D. Xenia K. Morin, Ph.D. Release date: November 1, 2013 For more information:
More informationGLYKOPEPTID- RESISTENS HOS ENTEROKOKKER
GLYKOPEPTID- RESISTENS HOS ENTEROKOKKER KRISTIN HEGSTAD Wirth 1994 Eur J Biochem 222:235-46 ENTEROCOCCI (1) Gram+, normal inhabitants of the gastrointestinal tract (GIT) Arias 2012 Nat Rev Microbiol 16:266-78
More informationScience for a healthy society. Food Safety & Security. Food Databanks. Food & Health. Industrial Biotechnology. Gut Health
Food Safety & Security Food Databanks Food & Health Industrial Biotechnology National Collection of Yeast Cultures Gut Health Science for a healthy society 1 invested in IFR delivers over 8 of benefits
More informationCopyright 1997 Scientific American, Inc. VIRUS BACTERIUM #1 VIRAL DNA CHROMOSOME DNA FROM BACTERIUM #1 BACTERIUM #2 CHROMOSOMAL FRAGMENTS COPIES
a VIRUS BACTERIUM #1 VIRAL CHROMOSOME b FROM BACTERIUM #1 c g VIRAL COPIES CHROMOSOMAL FRAGMENTS f BACTERIUM #2 d BACTERIAL e TRANSDUCING VIRUS SALLY BENSUSEN Bacterial Gene Swapping in Nature Genes travel
More informationCystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program
Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Introduction: Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and
More informationGene Cloning. Reference. T.A. Brown, Gene Cloning, Chapman and Hall. S.B. Primrose, Molecular Biotechnology, Blackwell
Gene Cloning 2004 Seungwook Kim Chem. & Bio. Eng. Reference T.A. Brown, Gene Cloning, Chapman and Hall S.B. Primrose, Molecular Biotechnology, Blackwell Why Gene Cloning is Important? A century ago, Gregor
More informationAttivita del Laboratorio Europeo di Riferimento sugli OGM (EURL-GMFF) in supporto al sistema di controllo ufficiale degli Stati Membri
Roma IZSLT 30 Novembre 2010 1 Attivita del Laboratorio Europeo di Riferimento sugli OGM (EURL-GMFF) in supporto al sistema di controllo ufficiale degli Stati Membri Marco Mazzara Joint Research Centre,
More informationMechanisms of Evolution
page 2 page 3 Teacher's Notes Mechanisms of Evolution Grades: 11-12 Duration: 28 mins Summary of Program Evolution is the gradual change that can be seen in a population s genetic composition, from one
More informationCHAPTER 6 GRIFFITH/HERSHEY/CHASE: DNA IS THE GENETIC MATERIAL IDENTIFICATION OF DNA DNA AND HEREDITY DNA CAN GENETICALLY TRANSFORM CELLS
CHAPTER 6 GRIFFITH/HERSHEY/CHASE: DNA IS THE GENETIC MATERIAL In 1928, Frederick Griffith was able to transform harmless bacteria into virulent pathogens with an extract that Oswald Avery proved, in 1944,
More informationChapter 20: Antimicrobial Drugs
Chapter 20: Antimicrobial Drugs 1. Overview of Antimicrobial Drugs 2. Antibacterial Drugs 3. Antiviral Drugs 4. Drugs for Eukaryotic Pathogens 1. Overview of Antimicrobial Drugs Antibiotics An antibiotic
More informationU.S. Meat Animal Research Center Clay Center, NE
Agricultural Research Clay Center, NE The (USMARC) was authorized by Congress on June 16, 1964, following transfer of the Naval Ammunition Depot from the Department of Defense to the Department of Agriculture.
More informationPatent issues in Industrial Biotech:
Patent issues in Industrial Biotech: Nucleic Acids, Life Forms & Natural Products Konrad Sechley PhD, Vancouver, Canada 18 April, 2016 OVERVIEW Gene patenting Life Forms & Natural Products Conclusions
More information(D) 181-183, 186-187, 190-193 TFYI 187 TPK 190
NEVADA Life Science Content Standards for Grade 8 Life s Structure and Function A From Bacteria to Plants B Animal Diversity C Human Body Systems D OBJECTIVES Content Standard 6.0: Structure and Function
More informationR. Landstorfer et al. BMC Genomics, 2014. Audrey Segura
Comparison of strand-specific transcriptomes of enterohemorrhagic Escherichia coli O157:H7 EDL933 under eleven different environmental conditions including radish sprouts and cattle feces R. Landstorfer
More informationUniversità Politecnica delle Marche
6 th Edition of the: UNIVPM - UNIDO E-Biosafety Master Summer ON CAMPUS SCUOLA DI DOTTORATO DELLA FACOLTA DI AGRARIA Ancona, June 17 21, 2013 Programme June 16, 2013 Arrival to Ancona Monday 17, June 2013-ROOM
More informationHSA Consumer Guide. Understanding Vaccines, Vaccine Development and Production. www.hsa.gov.sg November 2009. How a Vaccine Works.
November 2009 Understanding Vaccines, Vaccine Development and Production Vaccines, in general, help protect people from harmful infections before they come in contact with the disease. Vaccines may also
More informationMolecular and Cell Biology Laboratory (BIOL-UA 223) Instructor: Ignatius Tan Phone: 212-998-8295 Office: 764 Brown Email: ignatius.tan@nyu.
Molecular and Cell Biology Laboratory (BIOL-UA 223) Instructor: Ignatius Tan Phone: 212-998-8295 Office: 764 Brown Email: ignatius.tan@nyu.edu Course Hours: Section 1: Mon: 12:30-3:15 Section 2: Wed: 12:30-3:15
More informationThe European database of non-human VTEC strains
1 st Annual workshop of the EU Reference Laboratories for E. coli, Rome 1st Dec. 2006 The European database of non-human VTEC strains Gaia Scavia Dipartimento di Sanità Alimentare e Animale Istituto Superiore
More informationDepartment of Microbiology Vidyasagar University Midnapore - 721 102 West Bengal
S'yllabus for the I 'year FG Diploma Course in QUALITY CONTROL AND ASSURANCE IN MICROBIAL TECHNOLOGY (Semester Based: 400 marks in two semesters) Department of Microbiology Vidyasagar University Midnapore
More information